APOPTOSIS IS A PHYSIOLOGICAL MODE of cell death that is triggered by diverse external or internal signals. Apoptosis in pulmonary artery smooth muscle cells (PASMCs) allows the pulmonary vasculature to tightly control the vascular wall tissue mass (or thickness). Dysfunction of this process has been linked to pathogenesis of cancer, atherosclerosis, and pulmonary vascular diseases (15, 19, 25, 40) . Apoptosis in PASMCs and endothelial cells has been implicated in the regression of pulmonary arterial hypertrophy (9, 40) .
Cell shrinkage is an early hallmark in apoptosis. The apoptotic volume decrease has been demonstrated to result, at least in part, from a loss of intracellular K ϩ (6, 10, 35, 46) . Therefore, maintenance of a high concentration of intracellular K ϩ ([K ϩ ] i ) is required to maintain the cytosolic ion homeostasis necessary to preserve normal cell volume (21, 33, 46) . A sufficient [K ϩ ] i is also necessary for suppressing the activity of the caspases and nucleases (6, 22, 23) that are believed to be the final mediators of apoptosis (44) . An increase in K ϩ channel activity would therefore cause a loss of cytoplasmic K ϩ based on the outwardly directed electrochemical gradient of K ϩ across the plasma membrane. The resultant decrease in [K ϩ ] i would result in cell and nuclear shrinkage and facilitate the caspase (or nuclease)-mediated apoptosis (5, 6, 8, 11, 22, 23, 38, 46, 47, 50) . Furthermore, mitochondrial membrane depolarization, i.e., a decrease (less negative) in the mitochondrial membrane potential (⌬⌿ m ), is thought to be one of the contributory mechanisms in initiating apoptosis (20, 29, 51) . This study was designed to test whether activation of voltage-gated K ϩ (K V ) channels and ⌬⌿ m depolarization are involved in human PASMC apoptosis induced by staurosporine (ST), a potent inducer of apoptosis in a variety of cell types (17, 30) .
METHODS AND MATERIALS
Cell preparation. Human PASMCs (Clonetics) were seeded in flasks at a density of 2,500-3,500 cells/cm 2 and incubated in smooth muscle growth medium (Clonetics). The culture medium was changed after 24 h and every 48 h thereafter. Smooth muscle growth medium is composed of smooth muscle basal medium, 5% fetal bovine serum, 0.5 ng/ml of human epidermal growth factor, 2 ng/ml of human fibroblast growth factor, and 5 g/ml of insulin. The cells were subcultured and plated onto 10-or 25-mm coverslips with trypsin-EDTA buffer (Clonetics) when 70-90% confluence was achieved. The cells at passages 4-6 were used for experimentation.
Electrophysiological measurement. K ϩ currents (IK) were recorded with an Axopatch-1D amplifier and a DigiData 1200 interface (Axon Instruments) with patch-clamp techniques (18, 49) . Patch pipettes (2-4 M⍀) were made with a Sutter electrode puller with borosilicate glass tubes and fire polished on a Narishige microforge. Command voltage protocols and data acquisition were performed with pCLAMP soft-ware. Currents were filtered at 1-2 kHz (Ϫ3 dB) and digitized at 2-4 kHz by the amplifier. All experiments were performed at room temperature (22-24°C) .
For measurement of whole cell I K, a coverslip containing the cells was positioned in the recording chamber (Ϸ0.75 ml) and superfused (2 ml/min) with an extracellular (bath) physiological salt solution (PSS). The PSS contained (in mM) 141 NaCl, 4. . Nuclear morphology determination. The cells grown on 10-mm coverslips were first washed with PBS (Sigma), fixed in 95% ethanol, and stained with the membrane-permeable nucleic acid stain 4Ј,6Ј-diamidino-2-phenylindole (DAPI; Sigma). DAPI (5 M) was dissolved in an antibody buffer containing 500 mM NaCl, 20 M NaN 3, 10 M MgCl2, and 20 M Tris ⅐ HCl (pH 7.4). The blue fluorescence emitted at 461 nm was used to visualize the cell nuclei. The DAPI-stained cells were examined with a Nikon TE 300 fluorescence microscope, and the cell (nuclear) images were acquired with a high-resolution Solamere fluorescence imaging system. For each coverslip, 5-10 fields (with ϳ20-25 cells/field) were randomly selected to determine the percentage of apoptotic cells in the total cells based on the morphological characteristics of apoptosis. The cells with clearly defined nuclear breakage, remarkably condensed nuclear fluorescence, and a significantly shrunken cell body and nucleus were defined as apoptotic cells. To quantify apoptosis, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assays were also performed with an in situ cell death detection kit (TMR red; Boehringer Mannheim).
Measurement of rhodamine fluorescence. The cells grown on 25-mm coverslips were loaded with rhodamine 123 (R-123; Molecular Probes) by incubation with 10 g/ml for 30 min at 37°C. R-123 is taken up selectively by mitochondria (13, 14) , and its uptake is dependent of ⌬⌿ m. R-123 fluorescence was excited at 488 nm and measured at 530 nm with a GEN IV charge-coupled device camera connected to a Nikon TE 300 microscope. In isolated mitochondria, the relationship between R-123 fluorescence and ⌬⌿ m is linear. The R-123 fluorescence, which is quenched at resting ⌬⌿ m, increases with mitochondrial membrane depolarization (14) . The cells were perfused with PSS to establish a baseline of fluorescence, and then images were acquired every third second for 3 min during which the perfusate was changed at selective time points. The R-123 fluorescence signals were stored in a Macintosh computer and analyzed with QED software (Solamere) and a National Institutes of Health imaging system.
Colorimetric assay for ST-induced caspase-3 activation. The cells were plated on 10-cm petri dishes or in T-25 flasks. To measure the activity or concentration of caspase-3 in the lysates of PASMCs, we used the colorimetric caspase-3 assay kit (Sigma), and its detailed protocol is shown in the 96-well plate microassay method (Sigma). The cells were lysed, and the cytosolic contents devoid of the membrane and organelles were isolated before and after treatment with ST. A protease inhibitor cocktail for mammalian cells (Sigma), which was prepared as a 1:100 solution ready for use, was added to the lysis buffer to prevent enzymatic caspase-3 degradation. The caspase-3 activity was measured by incubating the cell lysates (for 90 min) with acetyl-Asp-Glu-Val-Asp p-nitroanilide, a caspase-3 substrate; its absorbance was measured at 405 nm after cleavage by caspase-3. The optical density value at 405 nm is thus used as indicative for the amount of caspase-3.
Solutions and chemicals. ST (Sigma) was prepared as a 1 mM stock solution in DMSO and diluted 10,000-50,000 times in PSS or the culture medium to make final concentrations of 0.02-0.1 M. 4-Aminopyridine (4-AP; Sigma) and TEA (Sigma) were directly dissolved in PSS or the culture medium at concentrations of 1-5 mM on the day of use; the pH of the 4-AP-containing solution was adjusted to 7.4 at room temperature. In high-K ϩ solution or culture medium, NaCl in PSS or the customized DMEM (Media Tech) was replaced, mole by mole, with KCl to maintain the osmolarity of the solution.
Statistics. The composite data are expressed as means Ϯ SE. Statistical analysis was performed with paired or unpaired Student's t-test or ANOVA and post hoc test (StudentNewman-Keuls) where appropriate. Differences were considered to be significant when P Ͻ 0.05. (Fig. 1 ). Similar results were obtained with the TUNEL assay. Raising extracellular K ϩ from 5 to 40 mM (which inhibits K ϩ efflux by reducing the outwardly directed K ϩ driving force) or the addition of 5 mM 4-AP (which blocks K V channels) markedly inhibited the ST-induced apoptosis (Fig. 1B) . Caspase-3 is a major effector molecule of many apoptotic inducers. An increase in caspase-3 concentration or activity causes apoptosis in a variety of cell types (26, 44) . Indeed, the ST-induced apoptosis was also accompanied by a significant increase in caspase-3 concentration; treatment of human PASMCs with 0.02 M ST for 20 h increased the concentration of caspase-3 in PASMC lysates from 21.0 Ϯ 0.6 to 31.0 Ϯ 1.2 M/10 5 cells (P Ͻ 0.01). Augmenting effect of ST on K V channel activity. Whole cell I K(V) was isolated in human PASMCs when the contribution of K Ca and K ATP channels to the current was minimized by removal of extracellular (bath) and intracellular (pipette) Ca 2ϩ and by the intracellular addition of 5 mM ATP, which completely blocks K ATP channels (7) . Extracellular application of 5 mM 4-AP (Fig. 2) or raising the extracellular K ϩ concentration to 40 mM (data not shown) significantly decreased the currents, suggesting that the currents were mainly generated by K ϩ efflux through 4-AP-sensitive K V channels (1, 37, 49) . Under these conditions, extracellular application of 0.1 M ST significantly increased whole cell I K(V) in human PASMCs in the presence of TEA (Fig. 3) , which blocks K Ca channels at doses Յ 1 mM (1). As shown in Fig. 3A , extracellular application of 0.1 M ST induced a 1.4-fold increase in the amplitude of I K(V) at Ϫ40 mV (from 16.1 Ϯ 1.1 to 39.1 Ϯ 4.2 pA) and a 2.9-fold increase at ϩ80 mV (from 327.8 Ϯ 38.6 to 1,293.7 Ϯ 146.6 pA; n ϭ 13 experiments; Fig. 3 , Aa-Ac). The ST-induced augmentation of I K(V) appeared to be voltage dependent (Fig. 3Ad) ; the effect was significantly enhanced at positive potentials ranging from ϩ20 to ϩ80 mV. Furthermore, extracellular application of ST (0.1 M) also increased the time constant of current inactivation at ϩ80 mV (Fig. 3Ae) . The voltage-dependent augmenting effect of ST on I K(V) was probably related to the decelerating effect on current inactivation at positive potentials.
RESULTS

Inhibitory effects of 40 mM K ϩ and 4-AP on STinduced apoptosis in human
Interestingly, the time course of the ST-induced activation of K V channels indicated a 15-to 20-min delay between the application of ST and the onset of the increase in I K(V) (Fig. 3B) . The ST-mediated activation of K V channels was almost completely blocked by extracellular application of 5 mM 4-AP (Fig. 3B, top) or by raising extracellular K ϩ from 4.7 to 40 mM (Fig. 3B,  bottom) , suggesting that the ST-induced increase in whole cell I K was predominantly due to activation of the 4-AP-sensitive K V channels.
The ST-induced increase in I K(V) precedes the STinduced apoptosis. Incubation of human PASMCs in medium containing the low dose (0.02 M) of ST that was used for the apoptosis experiments (Fig. 1) for 90 min also significantly increased the amplitude of I K(V) from 13.7 Ϯ 0.8 to 36.7 Ϯ 1.7 pA at Ϫ40 mV and from 377.4 Ϯ 22.9 to 1,094.7 Ϯ 42.4 pA at ϩ80 mV (P Ͻ 0.001; n ϭ 8-14 experiments; Fig. 4A ). Furthermore, ST treatment (0.02 M for 90 min) markedly decelerated the rate of I K(V) inactivation; the time constants of current inactivation at ϩ80 mV were 46.3 Ϯ 3.9 ms (n ϭ 14 experiments) and 69.6 Ϯ 8.6 ms (P Ͻ 0.001; n ϭ 9 experiments) in cells treated with vehicle (DMSO) and 0.02 M ST, respectively (Fig. 4Ac) .
To determine whether the ST-induced increase in I K(V) preceded its apoptotic effect, we compared the time courses of the ST-induced increase in I K(V) and apoptosis in human PASMCs treated with 0.02 M ST for up to 24 h. The ST-induced increase in I K(V) took place ϳ30 min after treatment of the cells with 0.02 M ST (Fig. 4B) . The time course of the ST-induced apoptosis indicated that the percentage of apoptotic nuclei was not significantly increased until 6 h after treatment with 0.02 M ST; the maximal effect occurred 20 h after treatment with ST (Fig. 4B ). These observations indicate that the ST-induced enhancement of I K(V) occurred before the onset of apoptosis in human PASMCs, suggesting that the increased I K(V) may play a causal role in initiating apoptosis (5, 6, 8, 10, 35, 38, 46, 47) .
Effect of ST on R-123 fluorescence.
The ⌬⌿ m is generated primarily by a proton gradient across the mitochondrial inner membrane (3). Mitochondrial membrane depolarization (less negative in ⌬⌿ m ) has been demonstrated to induce cytochrome c release from the mitochondrial intermembrane space to the cytosol (2, 9, 29, 51). Cytochrome c activates the cytosolic caspases, which are believed to be the final mediator of apoptosis in a variety of cell types (29, 44) . Whether ST-mediated apoptosis is due, in part, to ⌬⌿ m depolarization was examined by measuring the changes in R-123 fluorescence intensity in human PASMCs.
As shown in Fig. 5 , extracellular application of ST (0.02 M) rapidly increased R-123 fluorescence in human PASMCs. ⌬⌿ m is linearly related to the R-123 fluorescence intensity in vitro. The increase in R-123 fluorescence and the decrease in ⌬⌿ m indicated that the mitochondrial membrane was depolarized (13, 14) . However, increasing the extracellular K ϩ concentration from 5 to 40 mM, which decreases the driving force for K ϩ efflux across the plasma membrane, had negligible effect on the ST-induced increase in R-123 fluorescence (Fig. 5, B and C) . These results indicate that inhibition of K ϩ efflux across the plasma membrane (e.g., by reducing the transmembrane K ϩ driving force or blocking sarcolemmal K ϩ channels) does not interfere with the ST-induced depolarizing effect on ⌬⌿ m in PASMCs.
DISCUSSION
The precise control of the balance between PASMC proliferation and apoptosis plays an important role in maintaining normal pulmonary vascular structure and function. An increase in proliferation and a decrease in apoptosis of pulmonary vascular smooth muscle and endothelial cells would lead to pulmonary vascular remodeling and elevation of pulmonary vascular resistance and arterial pressure as observed in patients with pulmonary hypertension (9, 15, 16, 40, 43) .
The observations from this study demonstrated that apoptosis induced by ST is linked to mitochondrial membrane depolarization and activation of plasmalemmal K V channels in human PASMCs. The ⌬⌿ m depolarization would trigger the release of cytochrome c that activates caspases in the cytosol and induces apoptosis (20, 29, 51) . The increase in I K(V) would result in a loss of cytosolic K ϩ , which relieves the tonic suppression of K ϩ on the caspases and nucleases and therefore induces DNA degradation and apoptosis (6, 22, 23). Furthermore, the K ϩ loss would also lead to cell shrinkage (the apoptotic volume decrease), an early characteristic commonly used to identify apoptotic cells (5, 6, 10, 35, 46) . Inhibition of K ϩ efflux through K V channels with 40 mM K ϩ or 4-AP, a potent blocker of K V channels, negligibly affected the STinduced ⌬⌿ m depolarization but significantly attenuated the ST-induced apoptosis. These results suggest that ST mediates apoptosis in human PASMCs, at least in part, by two independent mechanisms: 1) ⌬⌿ m depolarization and 2) activation of K V channels in the plasma membrane.
K V channels are ubiquitously expressed in both excitable and nonexcitable cells (27, 37) and play important roles in the regulation of excitability, neurotransmitter release, muscle contraction, and cell volume, proliferation, and differentiation (12, 27, 39, 49) . At the molecular level, K V channels are homomeric and heteromeric tetramers composed of the pore-forming ␣-subunits and the regulatory ␤-subunits (27, 37) . The ␣-subunit is composed of six membrane-spanning segments termed S1 through S6, with a protein kinase C (PKC) binding site located intracellularly between the S4 and S5 segments (27) . The PKC-mediated phosphorylation of the ␣-subunits inhibits the K ϩ currents generated by K ϩ efflux through K V channels encoded by Kv1.1, Kv2.1, Kv4.1, or Kv4.2 (4), whereas PKCinduced phosphorylation of the Kv␤1.2 and Kv␤1.3 subunits is necessary for the inactivation of K V channels (31, 32, 34) . Therefore, inhibition of PKC would increase K V channel activity (4, 31, 32, 34) , promote K ϩ efflux, and induce a loss of cytosolic K ϩ . ST is a nonspecific inhibitor of PKC (17, 30) , and the ST-induced increase in I K(V) and apoptosis in human PASMCs may be, at least in part, due to the inhibition of PKC.
As mentioned earlier, cell shrinkage (the apoptotic volume decrease) due to the alterations in cell volume and the loss of intracellular K ϩ is an early requisite feature for the activation of the caspases and other cytosolic, proapoptotic enzymes (5, 6, 10, 22, 23, 35, 46) . Indeed, our observations indicated that ST-induced apoptosis was accompanied by a significant increase in caspase-3 concentration, and the decrease in K ϩ concentration in the assay buffer significantly reduced caspase-3 activity (data not shown). These results suggest that blockade of K V channels may attenuate PASMC apoptosis by diminishing the apoptotic volume decrease and caspase activity via maintaining a high concentration of cytosolic K ϩ . Due to the outwardly directed electrochemical gradient for K ϩ , opening of the plasmalemmal K ϩ channels would promote efflux or loss of cytosolic K ϩ and induce the apoptotic volume decrease and apoptosis. There are at least four types of K ϩ channels in vascular smooth muscle cells: 1) K V channels, 2) K Ca channels, 3) K ATP channels, and 4) inward rectifier K ϩ channels (27, 37) . In neurons, serum deprivation-and ST-mediated apoptosis is associated with an early enhancement of the delayed rectifier I K(V) , which leads to a net loss in cytosolic K ϩ and induces the apoptotic volume decrease. Pharmacological blockade of K V channels or attenuation of I K(V) with high extracellular K ϩ both inhibit the apoptotic volume decrease and apoptosis (8, 46, 47) . In Jurkat T cells, Fas/Fas ligand-mediated apoptosis is accompanied by a cytosolic K ϩ loss due to an increased K ϩ efflux (17) . More recently, activation of K Ca and K V channels has been shown to participate in pathways leading to cell apoptosis mediated by tumor necrosis factor (38) , ultraviolet radiation (45) , and carbonyl cyanide p-trifluoromethoxyphenylhydrazone (28) . These observations suggest that all K ϩ channels expressed in the plasma membrane may be involved in the apoptotic volume decrease and apoptosis.
Our study also showed that ST depolarizes ⌬⌿ m , which would trigger the release of cytochrome c and subsequently activate cytosolic caspases, such as caspase-3, and induce apoptosis (2, 3, 6, 17, 29, 30, 44) . This ⌬⌿ m -mediated apoptosis appears to be independent of cytosolic K ϩ loss because decreasing the K how ST mediates mitochondrial membrane depolarization in human PASMCs, 2) whether the ST-induced activation of K V channels interacts with the ST-mediated ⌬⌿ m depolarization in initiating apoptosis, and 3) whether ST induces ⌬⌿ m depolarization by affecting K ϩ channels in the mitochondrial inner membrane. Nevertheless, our observations imply that ST-induced apoptosis may involve multiple cellular pathways in human PASMCs. Recently, it has been found that the inner mitochondrial membrane contains multiple K ϩ channels such as K ATP and K Ca (11, 24, 36, 41, 42) ; therefore, it is possible that the ST-induced mitochondrial membrane depolarization is due to activation of the K ϩ channels in the mitochondrial membrane (11) . The function and expression of K V channels have been demonstrated to be inhibited in PASMCs from patients with primary pulmonary hypertension (48, 50) . The decreased activity of the K V channels is reported to be responsible, at least in part, for pulmonary vasoconstriction and PASMC proliferation (16, 39, 48, 50) . As shown in this study, inhibition of K V channel activity by pharmacological blockade of K V channels attenuated ST-induced apoptosis in PASMCs. These results direct us to speculate that the inhibited K V channel function and expression in PASMCs from patients with primary pulmonary hypertension may also contribute to enhance pulmonary vascular medial thickening via inhibition of PASMC apoptosis.
Pulmonary vasoconstriction and vascular smooth muscle proliferation both contribute to the elevated pulmonary vascular resistance and arterial pressure in patients with pulmonary hypertension (16, 40, 43) . Durmowicz and Stenmark (15) recently provided evidence that a lack of apoptosis plays a role in the vascular remodeling associated with chronic pulmonary hypertension. Our study demonstrated that ST-mediated activation of K V channels exerts an antiproliferative effect on human PASMCs by inducing apoptosis. The cellular mechanisms involved in the ST-induced apoptosis include 1) mitochondrial membrane depolarization, 2) activation of cytosolic caspase-3, and 3) activation of K V channels in the plasma membrane (Fig. 6) . By developing drugs specifically targeted to K V channels located in the pulmonary vasculature, we may find an effective alternative treatment for patients suffering from pulmonary hypertension.
